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Fermentation of Chicory Fructo-Oligosaccharides and
Native Inulin by Infant Fecal Microbiota Attenuates
Pro-Inflammatory Responses in Immature Dendritic Cells in
an Infant-Age-Dependent and Fructan-Specific Way
Madelon J. Logtenberg,* Renate Akkerman,* Ran An, Gerben D. A. Hermes, Bart J. de
Haan, Marijke M. Faas, Erwin G. Zoetendal, Henk A. Schols, and Paul de Vos
Scope: Inulin-type fructans are commonly applied in infant formula to
support development of gut microbiota and immunity. These inulin-type
fructans are considered to be fermented by gut microbiota, but it is unknown
how fermentation impacts immune modulating capacity and whether the
process of fermentation is dependent on the infant’s age.
Methods and results: The in vitro fermentation of chicory
fructo-oligosaccharides (FOS) and native inulin are investigated using pooled
fecal inocula of two- and eight-week-old infants. Both inocula primarily utilize
the trisaccharides in FOS, while they almost completely utilize native inulin
with degree of polymerization (DP) 3–8. Fecal microbiota of eight-week-old
infants degrades longer chains of native inulin up to DP 16. This correlates
with a higher abundance of Bifidobacterium and higher production of acetate
and lactate after 26 h of fermentation. Fermented FOS and native inulin
attenuate pro-inflammatory cytokines produced by immature dendritic cells
(DCs), but profiles and magnitude of attenuation are stronger with native
inulin than with FOS.
Conclusion: The findings demonstrate that fermentation of FOS and native
inulin is dependent on the infant’s age and fructan structure. Fermentation
enhances attenuating effects of pro-inflammatory responses in DCs, which
depend mainly on microbial metabolites formed during fermentation.
1. Introduction
The quality of postnatal nutrition is crucial for health later in life
as it is closely intertwined with the microbial colonization of the
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intestine and the development of the
gastrointestinal (GI) tract and immune
system.[1,2] Exclusive breastfeeding is the
gold standard for infants up to 6 months
as recommended by the World Health
Organization.[3] Human milk oligosac-
charides (HMOs) are an important com-
ponent of mother milk, which function
as prebiotics and boost immune develop-
ment for example by supporting the de-
velopment of the gut immune barrier.[4,5]
In Europe only approximately 25% of
the infants receive exclusive breastfeed-
ing up to an age of six months.[6] There
is infant formula available for infants for
which breast milk is not an option. These
formula are supplemented with non-
digestible carbohydrates (NDCs) such
as galacto-oligosaccharides and inulin
to mimic the health effects offered by
HMOs.[7,8]
A class of NDCs, commonly used in
infant formulas are inulin-type fructans.
Inulin-type fructans are generally iso-
lated from chicory roots and composed
of linear chains of 𝛽(2-1)-linked fruc-
tose monomers with varying degree of
polymerization (DP).[9] The chains can have either a glu-
cose (GF series) or fructose (F series) moiety at the reducing
end, which contributes to structural diversity of the inulin-
type fructans.[9] Native inulin predominantly contains the
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inulin-type GF series DP2-60, while the partial hydrolysis
product of inulin contains a DP2-10 GF and F series and
is referred to as fructo-oligosaccharides (FOS—synonym
oligofructose).
In recent years evidence has accumulated for the essence of
chain length in immunemodulation by inulin-type fructans.[10,11]
Previous in vitro studies demonstrated direct interaction of
inulin-type fructans with immune cells via pattern recognition
receptors (PRRs).[11] Inulin-type fructans with shorter chains
resulted in a more anti-inflammatory cytokine production
than inulin-type fructans with longer chains due to differ-
ences in stimulation of PRRs.[11] Besides the direct interaction,
inulin-type fructans can also affect immune responses via their
fermentation by specific bacteria resulting in the production of,
for example, SCFAs.[12,13] However, it is unknown how the fer-
mentation of inulin-type fructans by infant microbiota impacts
their immune modulating capacity and whether specific struc-
tures of the inulin-type fructans influence the fermentability and
immune effects.
As fermentation capacity is dependent on the age of infants,[14]
also the impact on immunity might be dependent on the age of
the infants. The microbial colonization of the infant gut starts
upon birth, when exposure occurs to maternal vaginal and envi-
ronmental bacteria.[15] Initially, due to the high concentration of
oxygen present in the gut of the new-born, aerobic and faculta-
tive anaerobic bacteria will colonize.[15] These bacteria will con-
sume oxygen and thereby create a more anaerobic environment
in the infant gut allowing colonization of strict anaerobic bacteria
such as clostridia and bifidobacteria.[15] This maturation process
most likely influences the utilization of NDCs in the first months
of life as different sets of enzymes will become available for the
degradation of NDCs depending on the bacteria present in the
infant gut.[14] In previous studies a clear difference in utilization
of HMOs was shown between two and eight week-old infants.[14]
Hence, both age groups were included in this study to be able
to study the effects of NDCs in this crucial timeframe of infant
microbiota development.
In the present study we investigated the fermentation of
chicory FOS and native inulin in an in vitro fermentation set-up
using pooled fecal inoculum of two and eight week-old infants,
whose bacterial functionality was found to be largely representa-
tive of the fecal inocula of the infant population in general (un-
published data). The ability of the infant fecal microbiota to de-
grade FOS and native inulin was studied as well as the production
of SCFAs and the microbiota composition in time. Fermentation
digesta at different time points were incubated with immature
dendritic cells derived from the umbilical vein to determine the




Frutalose OFP (FOS, DP2-10) and Frutafit IQ (native in-
ulin, DP2-60) were provided by Sensus (Roosendaal, The
Netherlands).
2.2. Fermentation of FOS and Native Inulin by Infant Fecal
Inoculum
2.2.1. Culture Medium
Standard ileal effluxmedium (SIEM; TritiumMicrobiology, Veld-
hoven, The Netherlands) was prepared as described elsewhere
with minor modifications.[16] Low amount of carbohydrates was
added to mimic the infant ideal environment while minimiz-
ing background fermentation. The carbohydrate medium com-
ponent contained (g L−1): pectin, 12; xylan, 12; arabinogalac-
tan, 12; amylopectin, 12; and starch, 12 with a final concentra-
tion of only 0.24 g L−1. The pH was adjusted to 5.8 using 2-(N-
morpholino)ethanesulfonic acid buffer.
2.2.2. Infant Fecal Inoculum
Fecal samples were collected from four exclusively breast-fed and
vaginally born infants. The infants did not receive antibiotic treat-
ment and did not have health issues. At an age of two and eight
weeks fecal material was collected from the diaper directly after
defecation, transferred to tubes and stored at −20 °C. After the
second collection time point, all samples were stored at −80 °C.
The inoculum was prepared as reported elsewhere with some
minor modifications.[17] After thawing, fecal material of four
infants were combined (4 × 0.1 gram) and diluted in 24 mL
sterilized NaCl solution (0.9% (w/v)) in an anaerobic chamber
(gas phase: 81% N2, 15% CO2, and 4% H2) (Bactron 300, Shel-
don Manufacturing, Cornelius, USA). Homogenization was per-
formed by the addition of sterile glass beads prior to thorough
mixing (2000 rpm). The fecal solution was combined with SIEM
medium in a ratio of 5:82 (v/v) and used as pooled fecal inoculum,
whose bacterial functionality was found to be largely equivalent
to that of the individual fecal inocula (unpublished data).
2.2.3. In Vitro Fermentation
Fermentations were performed in duplicate in an anaerobic
chamber. Fecal inoculum was combined with SIEM medium
containing FOS or native inulin in sterile fermentation flasks
in a ratio of 1:10 (v/v) with a total volume of 54 mL. The final
concentration of FOS and native inulin in the fermentation liq-
uid was 10 mg mL−1. The final concentration of SIEM medium
carbohydrates only reached 0.24 mg mL−1. Fermentation flasks
were closed with a rubber stopper that was secured with a metal
lid to ensure anoxic conditions. Afterwards flasks were put in an
incubator shaker (Innova 40) (37 °C, 100 rpm). At the start and
after 14, 20, and 26 h, digesta were collected in triplicate with a
syringe. One sample was immediately frozen in liquid nitrogen
and stored at −80 °C to preserve the bacteria for later microbial
analysis. Both other samples were heated for 5 min in a boiling
water bath to inactivate enzymes present. Subsequently theywere
stored at −20 °C until further analysis.
The following control fermentations were included: 1) inocu-
lumwithout added FOS and native inulin tomonitor background
fermentation, 2) FOS and native inulin without inoculum to
Mol. Nutr. Food Res. 2020, 2000068 2000068 (2 of 13) © 2020 The Authors. Published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
www.advancedsciencenews.com www.mnf-journal.com
monitor contamination of the substrate. From these latter con-
trols, only native inulin with SIEM showed some unexpected fer-
mentation after 26 h including inulin utilization and production
of substantial amounts of organic acids. Since a later control fer-
mentation using the same set-up and substrate did not show any
sign of fermentation/contamination, it was concluded that the
contamination of only the inulin control did not originate from
the substrate neither from SIEM. As such, it did not pose any
limitations for this study.
2.3. Fate of FOS and Native Inulin Upon Fermentation
Degradation of FOS and native inulin during fermentation
was analyzed by High Performance Anion Exchange Chro-
matography (HPAEC). Fermentation samples were diluted
until a concentration of 50 µg mL−1 and centrifuged (5 min,
15 000 g). Ten µL of sample was injected to an ISC5000 HPLC
system (Dionex, Sunnyvale, CA, USA) with a CarboPac PA-1
column (250 mm × 2 mm ID), a CarboPac PA guard column
(25 mm × 2 mm ID) and a ISC5000 ED detector (Dionex) in
the pulsed amperometic detector (PAD) mode. Mobile phase
A (0.1 m sodium hydroxide) and B (1 m sodium acetate in
0.1 m sodium hydroxide) were used with the following elution
profile: 0–25 min, 0–40% B; 25–30 min, 40–100% B; 30–35 min,
washing step with 100% B; 35–35.1 min, 100-0% B; 35.1–
50 min, equilibration with 100% A. Flow rate was set at 0.3 mL
min−1. The data were analyzed using Chromeleon 7.0 (Thermo
Scientific).
2.4. Production of SCFAs and Other Organic Acids upon
Fermentation
In order to quantify the production of SCFAs and organic acids,
fermentation samples were subjected to GC and HPLC analysis
as described elsewhere[18] with minor modifications.
For GC, fermentation samples (1mgml−1) weremixed in a 2:1
ratio with a solution containing HCl (0.3 m), oxalic acid (0.09 m)
and internal standard 2-ethyl butyric acid (0.45 mg mL−1).
The mixture was allowed to stand at room temperature for
30 min.
The temperature profile during GC analysis was as fol-
lows: 100 °C, maintained for 0.5 min; raised to 180 °C at 8 °C
min−1, maintained for 1 min; raised to 200 °C at 20 °C min−1,
maintained for 5 min. Glass wool was inserted in the glass
liner of the split injection port to protect the column from
contamination.[19]
2.5. Microbial Composition Analysis
2.5.1. DNA Extraction
DNA was extracted from fermentation samples using the re-
peated beat beating method[20] and afterwards purified using
the Maxwell 16 Tissue LEV Total RNA Purification Kit Cartridge
(AS1220).
2.5.2. PCR Amplification
Microbiota profiling was performed as described previously with
some modifications.[21] The V5V6 region of 16S ribosomal RNA
(rRNA) genes was amplified in triplicate PCR reactions with
a unique barcoded primer pair BSF784 (RGGATTAGATACCC)
and R1064 (CGACRRCCATGCANACCT). For the t0 samples
which contained 1.4-4.6 ng µL−1 DNA, 10 µL of DNA template
was used in each reaction. For samples with higher DNA con-
centrations, 0.7 µL of DNA template was used. Two synthetic
communities with known composition were included to evalu-
ate the sequencing performance for reflection of the theoreti-
cal composition.[22] The communities consisted of 55 16S rRNA
gene amplicons of phylotypes associated with the human gut
with staggered concentrations typical for the human gut (1) and
with relative abundances between 0.001 and 2.49% (2).
2.5.3. Library Preparation and Sequencing
PCR products were purified using HighPrep PCR kit (MagBio
Genomics, Alphen aan den Rijn, The Netherlands). Purified am-
plicons were quantified using Qubit dsDNA BR assay kit (Life
Technologies, Leusden, The Netherlands). Seventy unique bar-
code tags were used in each library.[22] Two amplicon pools were
formed by combining 200 ng of each barcoded sample and af-
terwards concentrated to 50 µL volume using the HighPrep PCR
kit. Libraries were sent for adapter ligation and sequencing on an
Illumina Hiseq2500 instrument (GATC-Biotech, Konstanz, Ger-
many).
2.5.4. Data Analysis
Processing and analysis of the 16S rRNAgene amplicon sequenc-
ing data was carried out using the NG-Tax pipeline, with default
settings[22] and R version 3.5.0. Amplicon sequencing variants
(ASVs) with a relative abundance below 0.1% were removed. The
threshold for taxonomic assignment was set at 80%.
Bifidobacteria were analyzed at the level of individual se-
quences (Amplicon Sequencing Variants [ASVs]). Species infor-
mation was obtained with NG-Tax 2.0[23] and SILVA database
release 132.[24] Tax4Fun2 was used to predict the functional capa-
bility of themicrobial communities based on 16S rRNA genes.[25]
Output was visualized in a heatmap with relative abundance of
KEGG functional orthologs in the fermentation samples scaled
per row and hierarchical clustering using theWard.D2 algorithm
and Euclidean distances using the pheatmap R package.[26]
UniProt Knowledgebase was used to extract all bacterial genes
encoding for 𝛽-fructofuranosidase together with the correspond-
ing taxonomic classification. Afterwards Bologna Unified Sub-
cellular Component Annotator (BUSCA) was used to predict the
subcellular localization of the enzyme.[27]
2.5.5. Quantification of Total Bacterial 16 rRNA Gene Copy Number
The total bacterial abundance was determined by quantita-
tive PCR (qPCR) analysis of total 16S rRNA genes using the
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forward primer 5’-GTGSTGCAYGGYYGTCGTCA-3’ and reverse
primer 3’-ACGTCRTCCMCNCCTTCCTC-5’.[28] qPCR amplifi-
cations were performed in triplicate and E. coli was used as stan-
dard for quantification. The qPCR reaction mixture contained
6.25 µL iQ SYBRGreen Supermix (Bio-Rad, Hercules, CA, USA),
200 nm forward and reverse primers, 3.25 uL of Nuclease free
water and 2.5 uL of sample DNA (1 ng µL). qPCR cycling con-
ditions and apparatus were used as described elsewhere with a
minor modification as an annealing temperature of 52 °C was
used instead of 56 °C.[29]
2.6. Stimulation of Dendritic Cells with FOS and Native Inulin
Fermentation Samples
2.6.1. Cell Culture and Stimulation
Dendritic cells (DCs) generated from umbilical cord blood
CD34+ progenitor cells (hematopoietic stem cells) were pur-
chased fromMatTek Corporation (Ashland,MA,USA). DCswere
freshly thawed and seeded into 96-well plates at a density of
70 × 104 cells per well and cultured under normal conditions
(37 °C, 21% O2 and 5% CO2) for 24 h according to manufac-
turer’s instructions. After 24 h of culturing, cells were attached,
and medium could be replaced. To stimulate DCs with fermen-
tation products of the in vitro fermentation of FOS and native in-
ulin using infant fecal inoculum, bacteria were removed from the
fermentation samples by centrifugation (10 min, RT, 12 000 g).
Subsequently supernatants were filtered through a 0.2 µm filter
and diluted in DC-MM culture medium (MatTek Corporation,
Ashland, MA, USA) containing Polymyxin-B (50 ng mL−1) (In-
vivogen) at a ratio of 1:10. The pH was set at 7.4 by the addi-
tion of 2 n NaOH. DCs were then incubated with 200 µL well−1
medium containing 20 µL of fermentation samples for 48 h. Af-
ter incubation supernatants were collected and stored at −20 °C
until further analysis. All experiments were repeated six times.
2.6.2. Assessment of Cytokine Expression
A magnetic Luminex Assay (R&D systems, Bio-Techne, Min-
neapolis, USA) was used to measure the levels of monocyte
chemoattractant protein-1 (MCP-1)/CC chemokine ligand
(CCL2), macrophage inflammatory protein 1-alpha (MIP-
1𝛼)/CCL3, IL-1𝛽, IL-6, IL-10, and tumour necrosis factor alpha
(TNF𝛼) in the DC supernatant. The assay was performed ac-
cording to manufacturer’s protocol. Briefly, cytokine standards
were resuspended and serial dilutions were prepared. Antibody
magnetic bead mix was added to a 96-well plate. Standards
and samples were added and incubated overnight at 4 °C while
shaking. After washing the plate three times, detection antibod-
ies were added and the plate was incubated for 30 min at RT
while shaking. After incubation, the plate was washed again and
incubated with streptavidin-PE for 30 min at RT while shaking.
Finally, the plate was washed again and 100 µL of wash buffer
was added to each well. Subsequently, the plate was analyzed
using a Luminex 200 System. The data obtained was analysed
using the Luminex xPONENT software.
2.6.3. Statistical Analysis
All statistical tests were performed using Prism 8 software
(GraphPad, San Diego, CA, USA). Outliers were removed after
testing using a Grubbs outlier test (alpha= 0.05). Data are shown
as averages and error bars represent standard error of the means.
Datawas distributed normally and analyzed using amixed-effects
model (REML) to test for differences between the two and eight
weeks groups, followed by a Tukey’smultiple comparisons test, to
test if the fermentation samples of either 14 or 26 h could induce
significantly higher cytokine responses than their corresponding
0h sample. The induced cytokine responses were also compared
by the FOS and native inulin samples at the different time points
to their corresponding blank samples.
3. Results
3.1. DP and Structure-Specific Utilization of FOS and Native
Inulin by Fecal Microbiota of Two and Eight Week-Old Infants
As it has been shown that fecal microbiota of two and eight
week-old infants have a different composition and consequently
a different expression of carbohydrate degrading enzymes,[14]
their ability to ferment FOS (DP2-10) and native inulin (DP2-60)
were compared. During in vitro fermentation, samples were
collected and analyzed with HPAEC to follow the fate of the
NDCs. A detailed overview of remaining DP after fermentation
of FOS and native inulin is shown in Figure S1, Supporting
Information.
Fecal microbiota of both two and eight week-old infants were
able to ferment the trisaccharides with either a terminal fructose
or glucose moiety (F and GF series) present in FOS, although
eight week-old infants did this at a higher rate (Figure 1). The
fermentation was limited to these DP3 oligomers during the first
14 h of fermentation. Between 14 and 26 h of fermentation also
only minor degradation of FOS DP > 3 took place, but fermenta-
tion of DP3 oligomers was still most pronounced. After 26 h of
fermentation, less than 3% of the DP3 oligomers was remaining,
while ≈77% of FOS DP > 3 was still intact with fecal microbiota
of two and eight week-old infants.
Fecal microbiota of two week-old infants were able to degrade
oligomers of native inulin up to DP9 while higher DPs remained
virtually intact (Figure 2). There was a relative high recovery of
62% and 99% for respectively DP 9–15 and DP ≥ 16 after 26 h
of fermentation. Longer incubation times did not result in sig-
nificant fermentation of higher DPs (Figure S2, Supporting In-
formation). The fecal microbiota of two week-old infants had a
similar preference for the trisaccharides F3 and GF2 during the
first 14 h of fermentation as was observed in the fermentation
study with FOS, although the F-series was less abundant in na-
tive inulin compared to FOS.
Fermentation of native inulin using fecal microbiota of two
week-old infants resulted in different degradation patterns com-
pared to the two week-old infants, as they were able to degrade
native inulin of higher DP values. The fecal microbiota of eight
week-old infants was able to completely degrade native inulin
up to DP16 and higher DPs were degraded for 40% after 26 h
of fermentation. Also, in this case a clear preference for the
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Figure 1. HPAEC profiles of FOS at the start and after 14, 20, and 26 h of fermentation using pooled fecal inoculum of A) two- and B) eight- week-old
infants. DP and F/GF series are annotated.
trisaccharides F3 and GF2 was observed during the first 14 h of
fermentation.
3.2. Impact of Native Inulin on fecal Microbiota Composition is
Different between Two and Eight Week-Old Infants
To study the impact of FOS and native inulin on the fecal micro-
biota of two and eight week-old infants, 16S rRNA gene amplicon
sequencing and quantitative PCR (qPCR) of total bacteria was
performed. With FOS fermentation, a decrease in relative abun-
dance of Bifidobacterium was observed in the first 14 h with both
fecal inocula of two and eight week-old infants (Figure 3, Table
S1, Supporting Information) as well as in control fermentations
without NDCs (Figure S3, Supporting Information). However,
taking into account quantitative PCR analysis of total bacteria
demonstrating a 2000-fold increase in 16S rRNA gene copy
numbers between 0 and 14 h of fermentation (Table S2, Support-
ing Information), fermentation of FOS increased the absolute
number of Bifidobacterium from 2.8 × 106 to 1.1 × 109 copies
in the first 14 h for inocula of 2-week-old infants. After 26 h
of fermentation 43–49% of the bacteria belonged to the genus
Bifidobacterium. A control fermentation without NDCs did not
result in an increase in Bifidobacterium (Figure S3, Supporting
Information).
Fermentation of FOS using fecal inoculum of two week-old
infants also resulted in an increase in Clostridium sensu stricto
resulting in a 11–16% contribution to all bacteria after 26 h. In
addition, an enrichment in bacteria belonging to the genera En-
terococcus, Escherichia-Shigella, and the family Enterobacteriaceae
was observed. This enrichment was also observed for control fer-
mentations without added NDCs.
FOS fermented by inoculum of eight week-old infants also
induced an increase in relative abundance of Bifidobacterium to
53–59% after 26 h of fermentation. Furthermore, a similar en-
richment in bacteria belonging to the genera Enterococcus and
Escherichia-Shigella, and the family Enterobacteriaceae was ob-
served. However, fermentation of FOS by fecal microbiota of
eight week-old infants did not result in an increase in the rela-
tive abundance of Clostridium sensu stricto.
Native inulin decreased the relative abundance of Bifidobac-
terium for inocula of two and eight week-old infants in the
first 14 h of fermentation. Again, the qPCR illustrated that
this relative decrease did not represent a decrease in absolute
numbers of Bifidobacterium (Table S2, Supporting Information).
After 26 h of fermentation the fecal microbiota of two week-old
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Figure 2. HPAEC profiles of native inulin at the start and after 14, 20, and 26 h of fermentation using pooled fecal inoculum of A) two- and B) eight-
week-old infants. DP and F/GF series are annotated.
infants was for 18% composed of bacteria belonging to the genus
Bifidobacterium. Clostridium sensu stricto was most abundant;
55% after 26 h of fermentation. Similar to the fermentation of
FOS, background fermentation of SIEM medium components
was observed.
Native inulin induced a higher increase in relative abundance
of Bifidobacterium for inocula of eight week-old infants than for
two week-old infants, but no relative increase inClostridium sensu
stricto was observed. After 26 h of fermentation 60–74% of the
bacteria belonged to the genus Bifidobacterium. Fermentation of
native inulin thus showed an age-dependent stimulation of Bifi-
dobacterium, which was not observed for FOS.
3.3. Differences in Predicted Functional Capabilities of Microbial
Communities from Two and Eight -Week-Old Infants during
Native Inulin Fermentation
As the degradation kinetics of native inulin differed between
the fecal microbiota of two and eight -week-old infants, we ques-
tioned whether this might be explained by differences in the pre-
dicted functional capability and more specifically in expression
of the enzymes 𝛽-fructofuranosidase and fructan 𝛽-fructosidase
which are necessary for degradation of native inulin. To this end,
an additional analysis was performed to predict the functional
capability of the microbial communities based on 16S rRNA
genes using Tax4Fun2 (Figure 4). The heatmap shows a clear
clustering based on fermentation time and infant age. With na-
tive inulin a higher relative abundance of 𝛽-fructofuranosidase
and fructan 𝛽-fructosidase was observed for fecal micro-
biota of eight week-old infants compared to two week-old
infants.
3.4. High Relative Abundance of One Specific ASV in
Fermentations of Both FOS and Native Inulin
Since mainly Bifidobacterium was increased by FOS and native
inulin, we performed a higher resolution analysis at the level
of their individual sequences (Amplicon Sequencing Variants
(ASVs)), which can be considered as a proxy for Bifidobacterium
species (Figure 5). ASV 2554220 was the most abundant ASV
during fermentations of both FOS and native inulin using fecal
inoculum of two and eight week-old infants. Comparison of the
sequence with the SILVA database release 132 showed that the se-
quence was an exact match with species such as Bifidobacterium
breve, Bifidobacterium longum subspecies infantis, and Bifidobac-
terium longum subspecies longum (Table 1).
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Figure 3. Relative abundance of bacteria at the highest classified taxonomy in duplicate fermentation digesta collected at the start and after 14 and 26 h
from in vitro fermentation of FOS and native inulin using pooled fecal inoculum of two and eight week-old infants with the 15 most abundant bacteria
visualized individually and less abundant bacteria summarized as “other”.
3.5. Extracellular 𝜷-fructofuranosidase not Detected in
Bifidobacterium Species Present in Fecal Microbiota of Eight
Week-Old Infants
As the expression of extracellular 𝛽-fructofuranosidase could be
essential for the utilization of long-chain inulin, we questioned
whether Bifidobacterium species present in the fecal microbiota
of eight week-old infants contain the gene that encodes for ex-
tracellular 𝛽-fructofuranosidase. The distribution of this gene
among bacterial genomes was investigated usingUniProtKB and
BUSCA (Figure 6). Only three out of 351 bacterial genes encoding
for extracellular 𝛽-fructofuranosidase belong to Bifidobacterium
species, namely to Bifidobacterium adolescentis, mongoliense, and
psychraerophilum. These Bifidobacterium species were not de-
tected in native inulin exposed microbiota of two and eight week-
old infants, suggesting that Bifidobacterium was not responsible
for the utilization of long-chain inulin.
3.6. SCFAs and Organic Acids Are Produced in an Age- and
Fructan-Dependent Fashion
Since SCFAs and other organic acids have shown to be pri-
mary fermentation metabolites with important immunomodu-
latory activity, SCFAs production during fermentation of FOS
and native inulin was quantified (Figure 7). Reproducibility was
confirmed with duplicate fermentations. A control fermentation
without added NDCs showed only minor production of organic
acids (Figure S4, Supporting Information).
Fermentation of FOS by fecal inoculum of two week-old
infants resulted in a total organic acid production of 5.8 µmol
mg−1 after 26 h in a ratio of 66:26:5:2:1 for respectively acetate,
lactate, succinate, butyrate, and propionate. Fermentation of FOS
by fecal inoculum of eight week-old infants resulted in a lower
amount of total organic acids produced (4.9 µmol mg−1). Acetate,
lactate, succinate, butyrate and propionate were produced in a
ratio of 73:18:7:1:1.
Differences in both total production and composition of
organic acids were observed for the fermentation of native inulin
using both inocula. The fermentation using fecal inoculum of
two week-old infants resulted in a total organic acid production
after 26 h of 4.5 µmol mg−1 with a considerable amount of
butyrate (0.9 µmol mg−1). Acetate, lactate, succinate, butyrate,
and propionate were produced in a ratio of 53:19:6:20:2. Fer-
mentation of native inulin by fecal inoculum of eight week-old
infants resulted in a two-fold higher amount of total organic
acids produced, namely 8.9 µmol mg−1. Acetate, lactate, suc-
cinate, butyrate and propionate were produced in a ratio of
72:22:4:1:1.
3.7. Fermentation Digesta of FOS and Native Inulin Induce
Infant’s Age-Dependent Cytokine Responses in Dendritic Cells
As in vivo the gastrointestinal tract is aligned with numerous
dendritic cells, we studied the impact of digesta of FOS and
native inulin fermentation on DC cytokine responses. We






















Figure 4. Heatmap of relative abundance of KEGG functional orthologs in fermentation digesta collected at the start and after 14 and 26 h from in vitro
fermentation of native inulin using pooled fecal inoculum of two and eight week-old infants. Colors given by taxa scaling per row with the mean relative
abundance in yellow. Hierarchical clustering using Ward.D2 algorithm and Euclidean distances. KEGG functional orthologs necessary for degradation
native inulin shown in figure. On top of the heatmap different colors as explained in the legend depict the infant age and fermentation time.
compared the impact of digesta of FOS and native inulin fer-
mented by fecal inocula from two and eight week-old infants.
To this end, DCs were incubated with fermentation digesta for
48h and the pro-inflammatory chemokines and cytokines MCP-
1/CLL2, MIP-1𝛼/CCL3, IL-1𝛽, IL-6, and TNF𝛼 as well as the anti-
inflammatory cytokine IL-10 induced in DCs were measured.
Digesta from control fermentations without added NDCs were
incubated with DCs (Figure 8). Both t = 14 and t = 26 di-
gesta of two and eight week inoculum significantly increased
the secretion of most chemokines and cytokines, when com-
pared to t = 0. Incubation of DCs with t = 14 digesta of
the control fermentation with two week inoculum significantly
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Figure 5. Relative abundance of Bifidobacterium Amplicon Sequencing
Variants (ASVs) in duplicate fermentation digesta collected at the start and
after 14 and 26 h from in vitro fermentation of FOS and native inulin using
pooled fecal inoculum of two and eight week-old infants.
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increased the chemokines MCP-1/CCL2 and MIP-1𝛼/CCL3, the
pro-inflammatory cytokines IL-1𝛽, IL-6, and TNF𝛼 but not the
anti-inflammatory cytokine IL-10. The t = 26 digesta induced a
significant increase of all chemokines and cytokines measured.
The total upregulation of all chemokines and cytokines wasmore
pronounced with microbiota of eight week-old infants.
Incubation of DCs with t = 14 FOS digesta of two week-
old infants inoculum significantly increased the levels of the












































Figure 6. Distribution of extracellular 𝛽-fructofuranosidase genes within
sequenced bacterial genomes on order level.
compared to digesta of t = 0, but levels were significantly lower
than the levels induced by t = 14 digesta of control fermenta-
tions with inocula of two week-old infants. Incubation of DCs
with t = 26 FOS digesta fermented with two week-old infant in-
oculum increased the same cytokines as well as IL-10 and TNF𝛼.
Again, the levels ofMIP-1𝛼/CCL3, IL-1𝛽 and IL-6were lower than
levels of these cytokines induced by the t = 26 digesta of control
fermentations.
DC incubationwith digesta of FOS fermented with eight week-
old infant inoculum resulted in different cytokine patterns. DCs
incubated with t = 14 FOS digesta significantly increased se-
cretion of the chemokines and cytokines MCP-1/CCL2, MIP-
1𝛼/CCL3, IL-1𝛽, and TNF𝛼when compared to t= 0.However, lev-
els ofMIP-1𝛼/CCL3, IL-1𝛽 and IL-6 as well as levels of TNF𝛼 were
significantly lower when compared to cytokine levels induced by
t= 14 digesta of control fermentationswith inocula of eight week-
old infants. With t = 26 digesta, levels of MCP-1/CCL2, MIP-
1𝛼/CCL3, IL-1𝛽, IL-10, and TNF𝛼 were significantly increased,
but levels of MIP-1𝛼/CCL3, IL-1𝛽, IL-6, and TNF𝛼 were still sig-
nificantly lower when compared to cytokine levels induced by
t= 26 digesta of control fermentationswith inocula of eight week-
old infants.
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Figure 7. Production of SCFAs, lactacte, and succinate upon fermentation
of A) FOS and native B) inulin using pooled fecal inoculum of two- and
eight-week-old infants.
When chemokine and cytokine secretion patterns between DC
stimulations with digesta of FOS fermentations with inoculum
of two and eight week-old infants were compared, significant dif-
ferences between age categories were found for secretion of IL-6
(p < 0.001).
Fermentation of native inulin also demonstrates a clear
age-dependent impact on DC cytokine responses. When DCs
where incubated with t = 14 native inulin digesta fermented
with inoculum of two week-old infants, levels of the chemokines
MCP-1/CCL2, MIP-1𝛼/CCL3 IL-1𝛽, IL-6 but also of IL-10 was
significantly increased. Notably, the level of MIP-1𝛼/CCL2 was
significantly higher and the level of TNF𝛼 was significantly lower
than that induced by t = 14 digesta of control fermentations. Na-
tive inulin t = 26 digesta only significantly increased secretion of
chemokine MIP-1𝛼/CCL3 and IL-6. The levels of the chemokine
MIP-1𝛼/CCL2 and the cytokines IL-1𝛽, IL-6, IL-10, and TNF𝛼
were all significantly lower when compared to the t = 26 digesta
of the control fermentation.
Results were different with eight week inoculum. DCs with
native inulin t = 14 digesta induced a significant increase in se-
cretion of all chemokines and cytokines measured. However, the
levels of MCP-1/CCL3, IL-1𝛽, IL-6, IL-10, and TNF𝛼 were all still
significantly lower than the levels of these cytokines induced by
the t = 14 digesta of the control fermentation. With native inulin
t = 26 digesta all cytokines significantly increased compared to
t = 0, but again MCP-1/CCL3, IL-1𝛽, IL-6, and TNF𝛼 were still
significantly lower than the levels of these cytokines induced by
the t = 26 digesta of the control fermentation with inoculum of
eight week-old infants.
When two and eight week-old infants were compared, sig-
nificant differences were found for secretion of chemokine
MIP-1𝛼/CCL3 (p < 0.001), the pro-inflammatory cytokine TNF𝛼
(p < 0.05) and the anti-inflammatory cytokine IL-10 (p < 0.001).
4. Discussion
Cow’s milk-based infant formulas are often substituted with
NDCs to mimic HMO functionalities. Chicory FOS and native
inulin are supplemented to infant formula, but to date minor
knowledge is available on structure-specific utilization of NDCs
by infant gut microbiota, production of SCFAs and concomitant
immune effects. Therefore, we investigated the degradation of
FOS and native inulin by infant fecal microbiota and the effect of
the fermentation digesta on dendritic cell responses.
Fermentation of FOS showed selective utilization of the trisac-
charides F3 and GF2 in both two and eight week-old infants,
which coincided with an increase in Bifidobacterium and an in-
creased production of mainly acetate and lactate. These organic
acids are important end products of the bifid shunt, which is a
unique hexosemetabolism pathway, and consequently suggested
to be mainly produced by Bifidobacterium.[30] The stimulation of
Bifidobacterium by FOS corroborates findings of a previous in
vivo study[31] in infants receiving FOS-supplemented infant for-
mula. The utilization of FOS by Bifidobacterium is attributed to
several properties such as expression of the gene that encodes
for 𝛽-fructofuranosidase, which is responsible for the cleavage of
the 𝛽 (2-1) bonds between the fructose units in FOS.[32]
Our data suggest that fermentation of FOSmostly benefit Bifi-
dobacterium breve, which is commonly found in the infant gut.[33]
In contrast to other Bifidobacterium species, Bifidobacterium breve
showed to have a similar preference for FOS DP3.[34] DP3 was
also first fermented when native inulin was used as substrate,
but here, in our study, DP 2–8 F and GF series were degraded
more extensively. This can be explained by the presence of higher
DPs and the relatively low abundance of DP3 (8% versus 32%) in
native inulin, what could have stimulated a broader range of bac-
terial enzymes.
Native inulin was fermented differently by fecal microbiota of
two and eight week-old infants. The fecal microbiota of eight
week-old infants fermented up to a higher DP than the two
week-old infants. This correlated with a higher relative increase
in Bifidobacterium and higher production of acetate and lactate.
Whereas most Bifidobacterium species utilize FOS by intracellu-
lar uptake and degradation, this uptake has been suggested to
be lower for longer inulin oligosaccharides due to their larger
size.[35] Previous studies have shown that the growth of Bifidobac-
terium on inulin is dependent on the transcription of extracellular
𝛽-fructofuranosidase.[36]
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Figure 8. Induced cytokines (fold change of induction by 0 h samples) by digesta of control fermentation, FOS and native inulin fermentation with
pooled fecal inocula of two and eight week-old infants. Stars above bars represent statistical different response compared to the 0h sample (*p < 0.05,
**p< 0.01, ***p< 0.001, ****p< 0.0001). Statistical differences between two and eight week groups are indicated above eight weeks graphs (#p< 0.05,
##p < 0.01, ###p < 0.001, ####p < 0.0001). Statistical differences between FOS and native inulin samples and their matched time sample of the
control fermentation are indicated above bars (a) p < 0.05, b) p < 0.01, c) p < 0.001, d) p < 0.0001).
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Extracellular 𝛽-fructofuranosidase is predominantly present
among bacterial orders such as Bacteroidales and Lactobacil-
lales. Bifidobacterium species which contain the gene encoding
for extracellular 𝛽-fructofuranosidase were not detected in fe-
cal microbiota of both two and eight week-old infants. There-
fore, it is possible that cross-feeding between Bifidobacterium
and other bacteria occurred during degradation of higher DPs
by the fecal microbiota of eight week-old infants. Similar cross-
feeding is reported between Lactobacillus salivarius and Lactobacil-
lus paracasei, where the latter uses an exo-inulinase to degrade
long-chain inulin.[37] However, it cannot be excluded that cer-
tain Bifidobacterium species can internalize native inulin DP 9–
16 by ABC transport systems, which was reported for Roseburia
inulinivorans.[32]
Along with Bifidobacterium, also a relative increase in Clostrid-
ium sensu stricto I was observed during fermentation of FOS
and native inulin by two week-old infants, which corresponded
with an increased production of butyrate. In contrast to Bifidobac-
terium, several Clostridium species ferment hexoses through the
Embden–Meyerhof–Parnas or pentose phosphate pathway with
butyrate being one of the important end products.[38] Although
Clostridium can utilize FOS and inulin,[39] the increase inClostrid-
ium sensu stricto in the control fermentation without added NDCs
indicate their increase is due to fermentation of SIEM medium
components.
Notably, more bacteria were stimulated by SIEMmedium. For
all fermentations an enrichment in bacteria belonging to the
genera Enterococcus and Escherichia–Shigella and the family En-
terobacteriaceae was observed in the first 14 h of fermentation.
These bacteria were reported to grow well on peptides and amino
acids which are highly abundant in SIEM medium: bactopep-
tone (24 g L−1), casein (24 g L−1), ox-bile (0.4 g L−1) and cysteine
(0.16 g L−1).[40] As the enrichment was also observed for con-
trol fermentations without added NDCs, it can be concluded that
their growth was stimulated by these medium components.
Fermentation as such had a strong impact on cytokine pro-
duction by immature umbilical vein derived dendritic cells. The
control fermentation digests without added NDCs with both two
and eight week-old infant inoculum induced high levels of the
chemokines and cytokines MCP-1/CLL2, MIP-1𝛼/CCL3, IL-1𝛽,
IL-6, and TNF𝛼 as well as the anti-inflammatory cytokine IL-
10. T = 0 digesta only induced minor cytokine production in
DCs, indicating that products formed during fermentation are
responsible for the observed effects. As production of SCFAs
in the control fermentation is very low, we assume that spe-
cific bacterial products such as adenosine triphosphate, lipotei-
choic acid, polysaccharide A, peptidoglycan, exopolysaccharide,
and RNA/DNA sequences produced by bacteria during fermen-
tation are responsible for these immune stimulating effects.[41]
These bacterial products interact with specialized immune recep-
tors on immune cells such as Toll like receptors that are expressed
on immune cells such as dendritic cells.[41]
Fermentation of FOS and native inulin reduced the induced
enhancement of cytokines by control fermentation. For FOS we
found a clear attenuation of the production of multiple pro-
inflammatory cytokines compared to the control fermentation.
This phenomenon could possibly be explained by the production
of SCFAs upon fermentation as shown here and by others.[42] A
very pronounced effect was observed for IL-6 secretion by DCs,
which was virtually gone with FOS digesta of fecal inoculum of
eight week-old infants and profoundly reduced with fecal inocu-
lum of two week-old infants fermenting FOS. For other cytokines
no significant differences were observed between FOS and the
control fermentation, which correlated with the similarities in
changes inmicrobiota composition and functionality between fe-
cal microbiota of two and eight week-old infants upon fermenta-
tion of FOS.
Native inulin also attenuated the production of pro-
inflammatory cytokines, however the profiles and magnitude
of attenuation were different than with FOS. Surprisingly, for
the digesta of two week-old infants this attenuation was more
pronounced after 26 h of fermentation for the cytokines MCP-
1/CCL2, IL-1𝛽, IL-10, and TNF𝛼. This specific native inulin-26h
fermentation sample was also found to have a high relative
increase in Clostridium sensu stricto I and increased production of
butyrate. Butyrate is known to be an immune attenuating SCFA
that acts via GPR109a receptor present on dendritic cells.[43]
Previous studies also found that butyrate altered the production
of pro-inflammatory cytokines as well as the anti-inflammatory
cytokine IL-10.[44] In addition, it was found that butyrate delayed
maturation of DCs and thereby influences T-cell polarization.[45]
The generation of butyrate from fermented native inulin
might therefore beneficially influence immune development as
butyrate can guide immune polarization.[45]
5. Concluding Remarks
This study provides insight into the complex relation between
the structure of fructans, the fecal microbiota composition, fer-
mentation capacity, SCFAs production and immune effects in in-
fants. Our data shows that differences in microbial functionality
between two and eight week-old infants impacts fermentation of
fructans and therewith the extent to which it performs attenua-
tion of pro-inflammatory responses in immature DCs. Our find-
ings may contribute to design and tailoring of NDCs mixtures
for substitution of infant formulas to meet the needs of infants
of different ages and state of inflammation.
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